Á lódáil...

Trastuzumab for HER2-Positive Metastatic Breast Cancer: Clinical and Economic Considerations

Trastuzumab is a recombinant humanized monoclonal antibody that selectively targets the extra-cellular domain of the HER2 receptor. It was approved by the FDA in September 1998 as the first targeted therapy for HER2-positive metastatic breast cancer, and has since led to significant improvements in...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Main Authors: Jeyakumar, Alwin, Younis, Tallal
Formáid: Artigo
Teanga:Inglês
Foilsithe: Libertas Academica 2012
Ábhair:
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3327515/
https://ncbi.nlm.nih.gov/pubmed/22518088
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/CMO.S6460
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!